Clinical Trial Update: Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on PI3K alpha inhibition in advanced/metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED